March 06, 2025

Butter Raises, Plant Oils Lower Mortality

New 33-year study of 221,054 adults finds replacing butter with plant-based oils could reduce premature death risk by 17%, with olive, canola, and soybean oils showing strongest protective effects against cancer and cardiovascular mortality.

Conexiant

March 06, 2025

Younger Age, Active SLE, Prednisone Tied to Pericarditis Recurrence

Researchers found that younger age, active systemic lupus erythematosus, and prednisone use significantly increase the risk of recurrent pericarditis in lupus patients.

Conexiant

March 06, 2025

Diabetes Control Declines, Especially Among Young Adults

Researchers find that U.S. diabetes prevalence remained stable from 2013 to 2023, but glycemic control worsened, particularly in young adults, a trend associated with increased cardiovascular risk.

Conexiant

March 06, 2025

An Estimated 31 Million Americans Borrowed for Medical Bills in 2024

A new West Health-Gallup Survey survey reveals insights into medical debt across all income levels and demographics in the United States.

Conexiant

March 06, 2025

Toxic Stress Linked to Higher Cardiovascular Risk in Younger Women

Toxic stress was associated with an increased odds of cardiovascular disease among younger women but not older women, study shows.

Conexiant

March 03, 2025

Type 1 Diabetes Linked to Lower Cardiovascular Event Rate

DM1 was associated with a lower probability of incident cardiovascular events than DM2, finds a new study analyzing over 162,000 patients from the Veradigm Metabolic Registry.

Conexiant

March 03, 2025

More States Fast Track Foreign-Trained Physicians

Since 2023, nine states have waived U.S. residency requirements for some foreign-trained physicians, with more states considering similar changes.

KFF Health News

March 03, 2025

SJS/TEN Linked to Increased Stroke, Heart Disease Risk

The risk of cardiovascular mortality in Stevens-Johnson syndrome survivors peaked within a year and persisted for up to 7 years.

Conexiant

March 03, 2025

FDA Approves First New Stroke Thrombolytic in 30 Years

The FDA has approved tenecteplase for acute ischemic stroke, offering a faster and simpler administration compared to alteplase based on findings from the AcT trial.

Conexiant